GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 159 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2017. The put-call ratio across all filers is 0.50 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $921,000 | -0.5% | 17,500 | 0.0% | 0.05% | -6.9% |
Q1 2019 | $926,000 | +0.2% | 17,500 | -22.2% | 0.06% | -18.3% |
Q4 2018 | $924,000 | +62.1% | 22,500 | +50.0% | 0.07% | +129.0% |
Q3 2018 | $570,000 | -15.9% | 15,000 | 0.0% | 0.03% | -18.4% |
Q2 2018 | $678,000 | -12.3% | 15,000 | -6.2% | 0.04% | -5.0% |
Q1 2018 | $773,000 | +44.5% | 16,000 | +17.6% | 0.04% | +60.0% |
Q4 2017 | $535,000 | -60.7% | 13,600 | -83.5% | 0.02% | -55.4% |
Q2 2016 | $1,363,000 | – | 82,200 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Logos Global Management LP | 850,000 | $46,869,000 | 6.00% |
Asymmetry Capital Management, L.P. | 155,232 | $8,559,000 | 5.50% |
Grace Capital | 124,749 | $6,878,000 | 5.33% |
Fernwood Investment Management, LLC | 187,477 | $10,337,000 | 4.88% |
Perceptive Advisors | 5,800,996 | $319,867,000 | 4.67% |
ArchPoint Investors | 217,510 | $11,993,000 | 3.83% |
GREAT POINT PARTNERS LLC | 655,676 | $36,154,000 | 3.25% |
Profit Investment Management, LLC | 42,196 | $2,328,000 | 1.44% |
Bain Capital Public Equity Management II, LLC | 381,868 | $21,056,000 | 1.39% |
Taylor Wealth Management Partners | 52,597 | $2,900,000 | 1.33% |